Cannabis Lab Announces International Expansion Plans
Digipath, Inc. is pleased to announce its plans to expand internationally. Colombia is the first foreign market in which Digipath plans to provide cannabis testing for both local consumers and cannabis exporters. Colombia is projected to be a significant cannabis exporter due to its climate and low cost of production and all cannabis products will need to be tested for potency and safety prior to export to any other country.
Colombia formally legalized medical marijuana in 2015. The country has realigned its interests to the export market in its current policy operations and is preparing to produce 40.5 tons of cannabis per year, starting in 2019.
Digipath has retained legal representation in Colombia, hired a local operations manager and is evaluating potential locations. "Clearly, international expansion presents a tremendous opportunity for Digipath and its shareholders," stated Todd Denkin, CEO, Digipath, Inc. "A fully-realized presence in South America could significantly increase our customer base. We expect Colombia to be one of the market leaders in cannabis, hemp and CBD production and are excited about the possibilities."
Through Digipath's Chief Science Officer Dr. Cindy Orser's work in Nevada, Digipath Labs helped pioneer cannabis lab testing protocols and implement one of the nation's most stringent cannabis safety regulations. This commitment to excellence has now positioned Digipath Labs as a market leader in the cannabis lab testing industry. The Company intends to carry the testing standards it has developed and proven in Nevada into these new international markets.
